Getting To Know JAKs and Other Emerging Therapies

Editorial| July 2020

The Pandemic of Screen Fatigue

Neal Bhatia, MD, FAAD

News| July 2020

Recent Developments

Digital Practice| July 2020

Hitting the Reset Button on Dermatology Practices

Instead of just restarting our practices after COVID-19, why don’t we hit reset? Here’s how.

Mark D. Kaufmann, MD, FAAD

Business Advisor| July 2020

The Power of Digital Marketing in Today’s Aesthetic Space

Bridgett Rowley

Financial Planner| July 2020

Why Has the Market Gone Up When Economic News Looks Grim?

A look at seven factors affecting the market.

David B. Mandell, JD, MBA, and Robert Peelman, CFP

Features| July 2020

Currents: Getting To Know JAKs and Other Emerging Therapies

Features| July 2020

Vitiligo: Oral and Topical JAKs Show Promise

Early studies offer some hope for emerging therapies for repigmentation.

Seemal Desai, MD

Features| July 2020

Update on Approaches to Hair Restoration

From investigational JAK inhibitors to eyebrow transplants, here’s a look at the latest in hair restoration.

Francisco Jimenez, MD, FISHRS

Features| July 2020

Investigational Oral Treatments for Psoriasis: A Review of Phase 2 and 3 Trials

Although biologic medications have proven to be highly effective in the treatment of psoriasis, there remains a need for oral medications that offer similar success rates. Here’s a look in the pipeline.

Donovan G. Kearns, BS; Shelley K. Uppal, BS; Vipawee S. Chat, BS; and Jashin J. Wu, MD, FAAD

Features| July 2020

CBD in the Holistic Practice of Dermatology

A growing body evidence suggests CBD may help with common symptoms of dermatologic diseases. Here’s what we know so far.

Jennifer Cather, MD

Features| July 2020

In the Pipeline: What to Know About Tapinarof

Here’s a closer look at the novel topical being studied for psoriasis and atopic dermatitis.

Features| July 2020

Physician Spotlight: Brett King, MD, PhD

Brett King, MD, PhD

Features| July 2020

Management of Atopic Dermatitis During the COVID-19 Pandemic

There is concern about the immunosuppressive or immunomodulatory effects of oral and biologic medications in patients with skin disease.

Shelley K. Uppal, BS; Donovan G. Kearns, BS; Vipawee S. Chat, BS; and Jashin J. Wu, MD, FAAD

Aesthetics Management| July 2020

Get to Know the Woodward Laser Lash Lift

The new CO₂laser lash lift results in naturally curled lashes and creates the appearance of bigger, brighter eyes.

Julie Woodward, MD

Clinical Focus| July 2020

Is Irritable Bowel Linked to Irritable Skin?

Exploring irritable bowel syndrome’s link to dermatologic conditions.

Marta Turowski, and Peter Lio, MD

Therapeutics Update| July 2020

新我的实践: OTC

Resident Resource Center| July 2020

The Impact of Socioeconomic Status in Atopic Dermatitis and How the Internet Can Act as a Public Health Intervention

DeAnna Diaz, MS, MBS, OMS-III; Sarah Li, OMS-III; Hanaa Khadraoui, OMS-III; Sonu Sahni, MD; and Chérie M. Ditre, MD